Market Analysts see Campbell Soup Company [CPB] gaining to $42. Time to buy?

Campbell Soup Company [NYSE: CPB] stock went on a downward path that fall over -2.98% on Thursday, amounting to a one-week price decrease of less than -5.04%. The company report on September 8, 2022 that CAMPBELL’S® CHUNKY® UNVEILS ‘CHUNKY SACKS HUNGER’ PROGRAM; PLEDGES TO DONATE ONE MILLION MEALS THIS NFL SEASON.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


PR Newswire.

Over the last 12 months, CPB stock rose by 11.20%. The one-year Campbell Soup Company stock forecast points to a potential upside of 0.83. The average equity rating for CPB stock is currently 3.20, trading closer to a bullish pattern in the stock market.

The market cap for the stock reached $14.45 billion, with 301.00 million shares outstanding and 193.87 million shares in the current float. Compared to the average trading volume of 2.39M shares, CPB stock reached a trading volume of 4514704 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Guru’s Opinion on Campbell Soup Company [CPB]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CPB shares is $48.24 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CPB stock is a recommendation set at 3.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

UBS have made an estimate for Campbell Soup Company shares, keeping their opinion on the stock as Sell, with their previous recommendation back on March 30, 2022. While these analysts kept the previous recommendation, RBC Capital Mkts dropped their target price from $47 to $46. The new note on the price target was released on March 28, 2022, representing the official price target for Campbell Soup Company stock. Previously, the target price had yet another drop from $51 to $43, while Piper Sandler kept a Neutral rating on CPB stock.

The Average True Range (ATR) for Campbell Soup Company is set at 1.10, with the Price to Sales ratio for CPB stock in the period of the last 12 months amounting to 1.69. The Price to Book ratio for the last quarter was 4.24, with the Price to Cash per share for the same quarter was set at 0.65. Price to Free Cash Flow for CPB in the course of the last twelve months was 31.01 with Quick ratio for the last quarter at 0.30.

CPB Stock Performance Analysis:

Campbell Soup Company [CPB] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -5.04. With this latest performance, CPB shares dropped by -3.70% in over the last four-week period, additionally plugging by 12.22% over the last 6 months – not to mention a rise of 11.20% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CPB stock in for the last two-week period is set at 34.47, with the RSI for the last a single of trading hit 27.25, and the three-weeks RSI is set at 39.99 for Campbell Soup Company [CPB]. The present Moving Average for the last 50 days of trading for this stock 49.40, while it was recorded at 48.89 for the last single week of trading, and 46.08 for the last 200 days.

Insight into Campbell Soup Company Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and Campbell Soup Company [CPB] shares currently have an operating margin of +13.64 and a Gross Margin at +30.68. Campbell Soup Company’s Net Margin is presently recorded at +8.84.

Return on Equity for this stock inclined to 23.35, with Return on Assets sitting at 6.41.

Campbell Soup Company’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.30 and a Current Ratio set at 0.70.


The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CPB. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Campbell Soup Company go to 2.52%.

Campbell Soup Company [CPB] Insider Position Details

There are presently around $7,418 million, or 53.20% of CPB stock, in the hands of institutional investors. The top three institutional holders of CPB stocks are: VANGUARD GROUP INC with ownership of 23,443,037, which is approximately 0.789% of the company’s market cap and around 0.10% of the total institutional ownership; BLACKROCK INC., holding 15,830,029 shares of the stock with an approximate value of $757.31 million in CPB stocks shares; and STATE STREET CORP, currently with $603.21 million in CPB stock with ownership of nearly 3.504% of the company’s market capitalization.

Positions in Campbell Soup Company stocks held by institutional investors increased at the end of September and at the time of the September reporting period, where 299 institutional holders increased their position in Campbell Soup Company [NYSE:CPB] by around 13,458,408 shares. Additionally, 213 investors decreased positions by around 11,343,221 shares, while 101 investors held positions by with 130,248,472 shares. The mentioned changes placed institutional holdings at 155,050,101 shares, according to the latest SEC report filing. CPB stock had 79 new institutional investments in for a total of 2,276,337 shares, while 48 institutional investors sold positions of 718,447 shares during the same period.


Please enter your comment!
Please enter your name here